The increased expression of HO1 in mice treated with sulforaphane or 2′,3′-dihydroxy-4′,6′-dimethoxychalcone in Parkinson’s disease models is restricted to astrocytes and microglia, and not expressed in neurons [60,85]. This evidence concerns the gene HMOX1 and Parkinson disease.